drug-eluting stents

angioplastia a tronco de coronaria izquierda vs cirugia

Left Main Coronary Artery Angioplasty vs. Surgery: A Large Meta-Analysis

Courtesy of Dr. Carlos&nbsp;Fava. Around 5% of patients undergoing coronary angiography present severe left main coronary artery (LMCA) lesions.&nbsp;Myocardial revascularization surgery (MRS) is the preferred method&nbsp;for this group, although there is evidence from different randomized trials demonstrating the safety and efficacy of unprotected LMCA angioplasty, with results similar to those obtained through the traditional strategy.<a href="https://solaci.org/en/2017/01/16/left-main-coronary-artery-angioplasty-vs-surgery-a-large-meta-analysis/" title="Read more" >...</a>

Angioplastia a tronco de coronaria izquierda no es inferior a la cirugía

Left Main Coronary Artery Angioplasty Would Be Non-Inferior to Surgery

Courtesy of Dr. Carlos&nbsp;Fava. Left main coronary artery (LMCA) lesions have always been defined as high-risk, with surgery as treatment of choice. Drug-eluting stents (DES) have slowly changed that, but their use still lacks strong supporting evidence. &nbsp; The Evaluation of XIENCE versus Coronary Artery Bypass Surgery for Effectiveness of Left Main Revascularization (EXCEL) study<a href="https://solaci.org/en/2016/11/09/left-main-coronary-artery-angioplasty-would-be-non-inferior-to-surgery/" title="Read more" >...</a>

operadores experimentados mortalidad

Experienced Operators: 50% Lower Mortality Rates?

Courtesy of Dr. Agustín Vecchia. &nbsp; The link between operator volume and clinical outcomes has been long and widely debated. After years of discussion, there are promoters and detractors. Currently, interventional cardiology societies all over the world classify centers as “high-volume” or “low-volume” using arbitrary parameters, and require training fellows to perform an also arbitrary number of<a href="https://solaci.org/en/2016/10/25/experienced-operators-50-lower-mortality-rates/" title="Read more" >...</a>

stents liberadores de farmacos

Xience V: Safe in “Real-Life” Bifurcation Lesions

Courtesy of Dr. Rodrigo Abreu. &nbsp; INTRODUCTION Bifurcation lesion treatment has evolved considerably in the last years: from balloon angioplasty (with high occlusion and restenosis rates) to bare metal stent angioplasty (with a procedural success around 86% and major adverse cardiac events [MACE] at 1 year around 32%). The subsequent emergence of drug-eluting stents (DES) reduced<a href="https://solaci.org/en/2016/09/09/xience-v-safe-in-real-life-bifurcation-lesions/" title="Read more" >...</a>

plataformas bioabsorvibles BVS

BVS: Safe and Effective in the Infrapatellar Area

Courtesy of Dr. Carlos Fava. Drug-eluting stents (DES) have shown mid-term benefit in lesions below the knee (BTK) by reducing the rate of acute occlusion and restenosis in type A and B lesions. However, failure to recover the self-regulatory functions of the local vessel could hinder future revascularization. Drug-eluting bioresorbable scaffolds (BVS) could be a solution to this problem.<a href="https://solaci.org/en/2016/09/02/bvs-safe-and-effective-in-the-infrapatellar-area/" title="Read more" >...</a>

terapia antitrombótica triple

Anticoagulation and PCI: How Long Should Triple Therapy Last?

The aim of this study was to compare clinical outcomes in relation to the duration of triple antithrombotic therapy in patients with indications for oral anticoagulation undergoing coronary angioplasty. The optimal period for the prescription of these three drugs has not been studied. &nbsp; Between 2009 and 2013, 8772 consecutive patients undergoing coronary angioplasty were included<a href="https://solaci.org/en/2016/08/30/anticoagulation-and-pci-how-long-should-triple-therapy-last/" title="Read more" >...</a>

TDAP duración óptima

Optimal Duration of DAPT: How to Predict Long-Term Events

Courtesy of Dr. Santiago F. Coroleu. &nbsp; Dual antiplatelet therapy (DAPT) with aspirin and clopidogrel after percutaneous coronary intervention (PCI) reduces the risk for coronary thrombotic events (CTEs) at the expense of increasing risk for major bleeding (MB). However, the lack of information to accurately predict the occurrence of each event in out-of-hospital patients under<a href="https://solaci.org/en/2016/08/17/optimal-duration-of-dapt-how-to-predict-long-term-events/" title="Read more" >...</a>

DES angioplastia primaria

DES in primary PCI: The Best Option?

Courtesy of Dr. Brian Nazareth Donato. &nbsp; The relative safety of drug-eluting stents (DES) and conventional bare-metal stents (BMS) in primary angioplasty (percutaneous coronary intervention, PCI) in patients with ST elevation myocardial infarction (STEMI) is still subject of debate. &nbsp; A search was carried out using Medline, CENTRAL, EMBASE, TCTMD and Cardiosource. There were 9673 patients included,<a href="https://solaci.org/en/2016/08/10/des-in-primary-pci-the-best-option/" title="Read more" >...</a>

DES in critical ischemia caused by infrapopliteal lesions

Original Title: Percutaneous Transluminal Angioplasty and Drug-Eluting Stents for Infrapopliteal Lesions in Critical Limb Ischemia (PADI) Trial. Reference: Marlon I. Spreen et al. Circ Cardiovasc Interv. 2016 Feb;9(2):e002376. &nbsp; The treatment of infrapopliteal lesions in patients with critical limb ischemia is limited by the high rates of restenosis. The most frequent course of treatment is<a href="https://solaci.org/en/2016/03/08/des-in-critical-ischemia-caused-by-infrapopliteal-lesions/" title="Read more" >...</a>

Diabetes has higher impact on DES outcomes than disease complexity

Original Title: Impact of diabetic status on outcomes after revascularization with drug-eluting stents in relation to coronary artery disease complexity. Reference: Koskinas KC et al. Circ Cardiovasc Intv. 2016; Epub ahead of print &nbsp; Diabetic patients ongoing PCI with drug eluting stents (DES) are at higher risk of repeat revascularization than non-diabetic patients. According to this<a href="https://solaci.org/en/2016/02/22/diabetes-has-higher-impact-on-des-outcomes-than-disease-complexity/" title="Read more" >...</a>

Top